ArticleFrontiers in genetics2021

Pegylated Liposomal Doxorubicin Versus Epirubicin as Adjuvant Therapy for Stage I-III Breast Cancer.

Wenxian Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.